These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 31787428)

  • 21. Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials.
    Viani GA; Stefano EJ; Afonso SL
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1405-18. PubMed ID: 19616743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens.
    Crawford ED; Schellhammer PF; McLeod DG; Moul JW; Higano CS; Shore N; Denis L; Iversen P; Eisenberger MA; Labrie F
    J Urol; 2018 Nov; 200(5):956-966. PubMed ID: 29730201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant hormonal therapy in carcinoma of the prostate.
    Lee HH; Warde P; Jewett MA
    BJU Int; 1999 Mar; 83(4):438-48. PubMed ID: 10210568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intermittent androgen deprivation therapy for prostate cancer: translating randomized controlled trials into clinical practice.
    Dason S; Allard CB; Wang JG; Hoogenes J; Shayegan B
    Can J Urol; 2014 Apr; 21(2 Supp 1):28-36. PubMed ID: 24775721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate cancer chemoprevention.
    Sandhu GS; Nepple KG; Tanagho YS; Andriole GL
    Semin Oncol; 2013 Jun; 40(3):276-85. PubMed ID: 23806493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypofractionation for clinically localized prostate cancer.
    Cabrera AR; Lee WR
    Semin Radiat Oncol; 2013 Jul; 23(3):191-7. PubMed ID: 23763885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brachytherapy versus external beam radiotherapy boost for prostate cancer: Systematic review with meta-analysis of randomized trials.
    Kee DLC; Gal J; Falk AT; Schiappa R; Chand ME; Gautier M; Doyen J; Hannoun-Levi JM
    Cancer Treat Rev; 2018 Nov; 70():265-271. PubMed ID: 30326422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant therapy for prostate cancer patients at high risk of recurrence following radical prostatectomy.
    Andriole GL
    Eur Urol; 1997; 32 Suppl 3():65-9. PubMed ID: 9267788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D in blood and risk of prostate cancer: lessons from the Selenium and Vitamin E Cancer Prevention Trial and the Prostate Cancer Prevention Trial.
    Schwartz GG
    Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1447-9. PubMed ID: 25085835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer.
    Seidenfeld J; Samson DJ; Aronson N; Albertson PC; Bayoumi AM; Bennett C; Brown A; Garber A; Gere M; Hasselblad V; Wilt T; Ziegler K
    Evid Rep Technol Assess (Summ); 1999 May; (4):i-x, 1-246, I1-36, passim. PubMed ID: 11098244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for prostate cancer: a Cochrane systematic review.
    Ilic D; O'Connor D; Green S; Wilt T
    Cancer Causes Control; 2007 Apr; 18(3):279-85. PubMed ID: 17206534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiotherapy for prostate cancer: the changing scene.
    Dearnaley DP
    Clin Oncol (R Coll Radiol); 1995; 7(3):147-50. PubMed ID: 7547515
    [No Abstract]   [Full Text] [Related]  

  • 33. Should asymptomatic progression following definitive local treatment for prostate cancer be treated?
    Lillis P; Thompson IM
    Hematol Oncol Clin North Am; 1996 Jun; 10(3):703-12. PubMed ID: 8773506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Target populations and strategies for chemoprevention trials of prostate cancer.
    Bostwick DG
    J Cell Biochem Suppl; 1994; 19():191-6. PubMed ID: 7823591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemohormonal Therapy for Hormone-Sensitive Prostate Cancer: A Review.
    Kyriakopoulos CE; Liu G
    Cancer J; 2016; 22(5):322-325. PubMed ID: 27749324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic overview of radiation therapy effects in prostate cancer.
    Nilsson S; Norlén BJ; Widmark A
    Acta Oncol; 2004; 43(4):316-81. PubMed ID: 15303499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of neoadjuvant and adjuvant therapy to prevent or delay recurrence of prostate cancer in patients undergoing radiation treatment for prostate cancer.
    Pisansky TM
    Urology; 2003 Dec; 62 Suppl 1():36-45. PubMed ID: 14747040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trials of breast and prostate cancer prevention.
    Greenwald P
    J Nutr; 2001 Jan; 131(1):176S-178S. PubMed ID: 11208959
    [No Abstract]   [Full Text] [Related]  

  • 39. Premalignancy in Prostate Cancer: Rethinking What we Know.
    De Marzo AM; Haffner MC; Lotan TL; Yegnasubramanian S; Nelson WG
    Cancer Prev Res (Phila); 2016 Aug; 9(8):648-56. PubMed ID: 26813971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate cancer screening.
    Alexander FE
    Microsc Res Tech; 2000 Dec; 51(5):419-22. PubMed ID: 11074611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.